Myrexis, Inc. Reports First Quarter Fiscal Year 2012 Results

SALT LAKE CITY, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and distinct mechanisms of action, today reported financial results for its fiscal first quarter ended September 30, 2011.

MORE ON THIS TOPIC